Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays

Summary: Typical enzymatic inhibition assays often demonstrate improved potency for kinase covalent inhibitors compared to reversible inhibitors. This can primarily be attributed to the irreversible mode of action and could affect the evaluations of the ATP-competitive nature of covalent inhibitors,...

Full description

Bibliographic Details
Main Authors: Martin Schröder, Apirat Chaikuad
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266616672100424X
id doaj-2681d2892e6c4a1984cfc58599de1c01
record_format Article
spelling doaj-2681d2892e6c4a1984cfc58599de1c012021-09-19T05:00:44ZengElsevierSTAR Protocols2666-16672021-09-0123100717Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assaysMartin Schröder0Apirat Chaikuad1Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, 60438 Frankfurt, Germany; Structural Genomics Consortium, BMLS, Goethe-University Frankfurt, 60438 Frankfurt, Germany; Corresponding authorInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, 60438 Frankfurt, Germany; Structural Genomics Consortium, BMLS, Goethe-University Frankfurt, 60438 Frankfurt, Germany; Corresponding authorSummary: Typical enzymatic inhibition assays often demonstrate improved potency for kinase covalent inhibitors compared to reversible inhibitors. This can primarily be attributed to the irreversible mode of action and could affect the evaluations of the ATP-competitive nature of covalent inhibitors, hindering optimization of these compounds. Here, we describe a version of ADP-Glo assay, in which modification of inhibitor incubation time in the presence or absence of ATP enables a quick assessment of relative reversible and irreversible effects of kinase covalent inhibitors.For complete details on the use and execution of this protocol, please refer to Schröder et al. (2020).http://www.sciencedirect.com/science/article/pii/S266616672100424XSingle-molecule AssaysHigh Throughput ScreeningMolecular/Chemical ProbesProtein BiochemistryChemistry
collection DOAJ
language English
format Article
sources DOAJ
author Martin Schröder
Apirat Chaikuad
spellingShingle Martin Schröder
Apirat Chaikuad
Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
STAR Protocols
Single-molecule Assays
High Throughput Screening
Molecular/Chemical Probes
Protein Biochemistry
Chemistry
author_facet Martin Schröder
Apirat Chaikuad
author_sort Martin Schröder
title Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
title_short Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
title_full Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
title_fullStr Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
title_full_unstemmed Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
title_sort assessing reversible and irreversible binding effects of kinase covalent inhibitors through adp-glo assays
publisher Elsevier
series STAR Protocols
issn 2666-1667
publishDate 2021-09-01
description Summary: Typical enzymatic inhibition assays often demonstrate improved potency for kinase covalent inhibitors compared to reversible inhibitors. This can primarily be attributed to the irreversible mode of action and could affect the evaluations of the ATP-competitive nature of covalent inhibitors, hindering optimization of these compounds. Here, we describe a version of ADP-Glo assay, in which modification of inhibitor incubation time in the presence or absence of ATP enables a quick assessment of relative reversible and irreversible effects of kinase covalent inhibitors.For complete details on the use and execution of this protocol, please refer to Schröder et al. (2020).
topic Single-molecule Assays
High Throughput Screening
Molecular/Chemical Probes
Protein Biochemistry
Chemistry
url http://www.sciencedirect.com/science/article/pii/S266616672100424X
work_keys_str_mv AT martinschroder assessingreversibleandirreversiblebindingeffectsofkinasecovalentinhibitorsthroughadpgloassays
AT apiratchaikuad assessingreversibleandirreversiblebindingeffectsofkinasecovalentinhibitorsthroughadpgloassays
_version_ 1717376105240854528